133 related articles for article (PubMed ID: 38378246)
1. The difficulty with measuring the largest melanoma tumour diameter in sentinel lymph nodes.
Laeijendecker AE; El Sharouni MA; Stathonikos N; Spoto CPE; van de Wiel BA; Eijken EJE; Mulder M; Mooyaart AL; Szumera-Cieckiewicz A; Mihic-Probst D; Massi D; Cook M; Koljenovic S; Alos L; van Diest PJ; van Akkooi ACJ; Blokx W
J Clin Pathol; 2024 May; 77(6):372-377. PubMed ID: 38378246
[TBL] [Abstract][Full Text] [Related]
2. High discordance rate in assessing sentinel node positivity in cutaneous melanoma: Expert review may reduce unjustified adjuvant treatment.
El Sharouni MA; Laeijendecker AE; Suijkerbuijk KP; Witkamp AJ; Sigurdsson V; van Diest PJ; van Gils CH; Blokx WA
Eur J Cancer; 2021 May; 149():105-113. PubMed ID: 33848712
[TBL] [Abstract][Full Text] [Related]
3. Expert opinion in melanoma: the sentinel node; EORTC Melanoma Group recommendations on practical methodology of the measurement of the microanatomic location of metastases and metastatic tumour burden.
van Akkooi AC; Spatz A; Eggermont AM; Mihm M; Cook MG
Eur J Cancer; 2009 Nov; 45(16):2736-42. PubMed ID: 19767199
[TBL] [Abstract][Full Text] [Related]
4. Sentinel node tumor burden in prediction of prognosis in melanoma patients.
Palve J; Ylitalo L; Luukkaala T; Jernman J; Korhonen N
Clin Exp Metastasis; 2020 Apr; 37(2):365-376. PubMed ID: 32076905
[TBL] [Abstract][Full Text] [Related]
5. Sentinel lymph nodes containing very small (<0.1 mm) deposits of metastatic melanoma cannot be safely regarded as tumor-negative.
Murali R; DeSilva C; McCarthy SW; Thompson JF; Scolyer RA
Ann Surg Oncol; 2012 Apr; 19(4):1089-99. PubMed ID: 22271204
[TBL] [Abstract][Full Text] [Related]
6. Pathologic examination of sentinel lymph nodes from melanoma patients.
Scolyer RA; Murali R; McCarthy SW; Thompson JF
Semin Diagn Pathol; 2008 May; 25(2):100-11. PubMed ID: 18697713
[TBL] [Abstract][Full Text] [Related]
7. The sentinel node invasion level (SNIL) as a prognostic parameter in melanoma.
Kretschmer L; Mitteldorf C; Hellriegel S; Leha A; Fichtner A; Ströbel P; Schön MP; Bremmer F
Mod Pathol; 2021 Oct; 34(10):1839-1849. PubMed ID: 34131294
[TBL] [Abstract][Full Text] [Related]
8. Melanoma-specific survival in patients with positive sentinel lymph nodes: Relevance of sentinel tumor burden.
Satzger I; Leiter U; Gräger N; Keim U; Garbe C; Gutzmer R
Eur J Cancer; 2019 Dec; 123():83-91. PubMed ID: 31677550
[TBL] [Abstract][Full Text] [Related]
9. Sentinel node biopsy in melanoma: Current controversies addressed.
Madu MF; Wouters MW; van Akkooi AC
Eur J Surg Oncol; 2017 Mar; 43(3):517-533. PubMed ID: 27590685
[TBL] [Abstract][Full Text] [Related]
10. No non-sentinel node involvement in melanoma patients with limited Breslow thickness and low sentinel node tumour load.
Bogenrieder T; van Dijk MR; Blokx WA; Ramrath K; Seldenrijk K; Stolz W; van Diest PJ
Histopathology; 2011 Aug; 59(2):318-26. PubMed ID: 21884211
[TBL] [Abstract][Full Text] [Related]
11. The prognostic significance of sentinel node tumour burden in melanoma patients: an international, multicenter study of 1539 sentinel node-positive melanoma patients.
van der Ploeg AP; van Akkooi AC; Haydu LE; Scolyer RA; Murali R; Verhoef C; Thompson JF; Eggermont AM
Eur J Cancer; 2014 Jan; 50(1):111-20. PubMed ID: 24074765
[TBL] [Abstract][Full Text] [Related]
12. Interobserver reproducibility of histologic parameters of melanoma deposits in sentinel lymph nodes: implications for management of patients with melanoma.
Murali R; Cochran AJ; Cook MG; Hillman JD; Karim RZ; Moncrieff M; Starz H; Thompson JF; Scolyer RA
Cancer; 2009 Nov; 115(21):5026-37. PubMed ID: 19658180
[TBL] [Abstract][Full Text] [Related]
13. Risk stratification of sentinel node-positive melanoma patients defines surgical management and adjuvant therapy treatment considerations.
Verver D; van Klaveren D; van Akkooi ACJ; Rutkowski P; Powell BWEM; Robert C; Testori A; van Leeuwen BL; van der Veldt AAM; Keilholz U; Eggermont AMM; Verhoef C; Grünhagen DJ
Eur J Cancer; 2018 Jun; 96():25-33. PubMed ID: 29660597
[TBL] [Abstract][Full Text] [Related]
14. Melanoma patient staging: histopathological versus molecular evaluation of the sentinel node.
Davids V; Kidson SH; Hanekom GS
Melanoma Res; 2003 Jun; 13(3):313-24. PubMed ID: 12777989
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node assessment in melanoma: current state and future directions.
Cheng TW; Hartsough E; Giubellino A
Histopathology; 2023 Nov; 83(5):669-684. PubMed ID: 37526026
[TBL] [Abstract][Full Text] [Related]
16. Prognosis in patients with sentinel node-positive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteria.
van der Ploeg AP; van Akkooi AC; Rutkowski P; Nowecki ZI; Michej W; Mitra A; Newton-Bishop JA; Cook M; van der Ploeg IM; Nieweg OE; van den Hout MF; van Leeuwen PA; Voit CA; Cataldo F; Testori A; Robert C; Hoekstra HJ; Verhoef C; Spatz A; Eggermont AM
J Clin Oncol; 2011 Jun; 29(16):2206-14. PubMed ID: 21519012
[TBL] [Abstract][Full Text] [Related]
17. The detection and significance of melanoma micrometastases in sentinel nodes.
Scolyer RA; Murali R; Satzger I; Thompson JF
Surg Oncol; 2008 Sep; 17(3):165-74. PubMed ID: 18639451
[TBL] [Abstract][Full Text] [Related]
18. Subcostal lymph nodes: An unusual sentinel lymph node basin in cutaneous melanoma.
Marsh KM; Lattimore CM; Cramer CL; Slingluff CL; Dengel LT
J Surg Oncol; 2022 Dec; 126(7):1272-1278. PubMed ID: 35870116
[TBL] [Abstract][Full Text] [Related]
19. Value of micromorphometric criteria of sentinel lymph node metastases in predicting further nonsentinel lymph node metastases in patients with melanoma.
Fink AM; Weihsengruber F; Duschek N; Schierl M; Wondratsch H; Jurecka W; Rappersberger K; Steiner A
Melanoma Res; 2011 Apr; 21(2):139-43. PubMed ID: 21317817
[TBL] [Abstract][Full Text] [Related]
20. An updated European Organisation for Research and Treatment of Cancer (EORTC) protocol for pathological evaluation of sentinel lymph nodes for melanoma.
Cook MG; Massi D; Szumera-Ciećkiewicz A; Van den Oord J; Blokx W; van Kempen LC; Balamurugan T; Bosisio F; Koljenović S; Portelli F; van Akkooi ACJ;
Eur J Cancer; 2019 Jun; 114():1-7. PubMed ID: 31005015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
